1. Home
  2. RVMD vs CACC Comparison

RVMD vs CACC Comparison

Compare RVMD & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • CACC
  • Stock Information
  • Founded
  • RVMD 2014
  • CACC 1972
  • Country
  • RVMD United States
  • CACC United States
  • Employees
  • RVMD N/A
  • CACC N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • CACC Finance: Consumer Services
  • Sector
  • RVMD Health Care
  • CACC Finance
  • Exchange
  • RVMD Nasdaq
  • CACC Nasdaq
  • Market Cap
  • RVMD 7.5B
  • CACC 6.3B
  • IPO Year
  • RVMD 2020
  • CACC 1992
  • Fundamental
  • Price
  • RVMD $36.63
  • CACC $465.10
  • Analyst Decision
  • RVMD Strong Buy
  • CACC Sell
  • Analyst Count
  • RVMD 12
  • CACC 2
  • Target Price
  • RVMD $69.50
  • CACC $475.00
  • AVG Volume (30 Days)
  • RVMD 1.5M
  • CACC 96.7K
  • Earning Date
  • RVMD 08-06-2025
  • CACC 07-31-2025
  • Dividend Yield
  • RVMD N/A
  • CACC N/A
  • EPS Growth
  • RVMD N/A
  • CACC 143.69
  • EPS
  • RVMD N/A
  • CACC 34.75
  • Revenue
  • RVMD N/A
  • CACC $1,173,200,000.00
  • Revenue This Year
  • RVMD N/A
  • CACC $157.38
  • Revenue Next Year
  • RVMD $234.26
  • CACC $4.19
  • P/E Ratio
  • RVMD N/A
  • CACC $12.98
  • Revenue Growth
  • RVMD N/A
  • CACC 43.92
  • 52 Week Low
  • RVMD $29.17
  • CACC $409.22
  • 52 Week High
  • RVMD $62.40
  • CACC $560.00
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 51.68
  • CACC 38.27
  • Support Level
  • RVMD $36.20
  • CACC $433.73
  • Resistance Level
  • RVMD $38.60
  • CACC $533.70
  • Average True Range (ATR)
  • RVMD 1.25
  • CACC 15.39
  • MACD
  • RVMD 0.09
  • CACC -7.33
  • Stochastic Oscillator
  • RVMD 56.43
  • CACC 31.38

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

Share on Social Networks: